Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The daily Top 10 COVID papers


  Influenza

  Free Subscription


04.01.2021

3 Am J Med
12 Ann Intern Med
1 Antimicrob Agents Chemother
1 BMC Pediatr
11 BMJ
1 Eur J Epidemiol
13 J Clin Microbiol
1 J Epidemiol Community Health
12 J Infect
1 J Infect Dis
3 J Virol
5 Lancet
11 N Engl J Med
1 PLoS Biol
1 PLoS Genet
29 PLoS One
3 Proc Natl Acad Sci U S A
3 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Med

  1. SOLANO JJ, Maki DG, Adirim TA, Shih RD, et al
    Public Health Strategies Contain and Mitigate COVID-19: A Tale of Two Democracies.
    Am J Med. 2020;133:1365-1366.
    PubMed        

  2. KRITTANAWONG C, Narasimhan B, Virk HUH, Narasimhan H, et al
    Misinformation Dissemination in Twitter in the COVID-19 Era.
    Am J Med. 2020;133:1367-1369.
    PubMed        

  3. KITTLESON MM
    Trust in the Time of COVID-19.
    Am J Med. 2020;133:1370-1371.
    PubMed        


    Ann Intern Med

  4. RESTIVO DA, Centonze D, Alesina A, Marchese-Ragona R, et al
    Myasthenia Gravis Associated With SARS-CoV-2 Infection.
    Ann Intern Med. 2020 Aug 10. doi: 10.7326/L20-0845.
    PubMed        

  5. FOX SE, Lameira FS, Rinker EB, Vander Heide RS, et al
    Cardiac Endotheliitis and Multisystem Inflammatory Syndrome After COVID-19.
    Ann Intern Med. 2020 Jul 29. doi: 10.7326/L20-0882.
    PubMed        

  6. MOURAD A
    The Remote Misses of COVID-19.
    Ann Intern Med. 2020 Aug 19. doi: 10.7326/M20-4984.
    PubMed        

  7. SCHWARTZ R, Sinskey JL, Anand U, Margolis RD, et al
    Addressing Postpandemic Clinician Mental Health : A Narrative Review and Conceptual Framework.
    Ann Intern Med. 2020 Aug 21. doi: 10.7326/M20-4199.
    PubMed         Abstract available

  8. KANG M, Wei J, Yuan J, Guo J, et al
    Probable Evidence of Fecal Aerosol Transmission of SARS-CoV-2 in a High-Rise Building.
    Ann Intern Med. 2020 Sep 1. doi: 10.7326/M20-0928.
    PubMed         Abstract available

  9. FISHER KA, Bloomstone SJ, Walder J, Crawford S, et al
    Attitudes Toward a Potential SARS-CoV-2 Vaccine: A Survey of U.S. Adults.
    Ann Intern Med. 2020 Sep 4. doi: 10.7326/M20-3569.
    PubMed         Abstract available

  10. GERBERDING JL
    Measuring Pandemic Impact: Vital Signs From Vital Statistics.
    Ann Intern Med. 2020;173:1022-1023.
    PubMed        

  11. KIANG MV, Irizarry RA, Buckee CO, Balsari S, et al
    Every Body Counts: Measuring Mortality From the COVID-19 Pandemic.
    Ann Intern Med. 2020 Sep 11. doi: 10.7326/M20-3100.
    PubMed         Abstract available

  12. BOUTRON I, Chaimani A, Meerpohl JJ, Hrobjartsson A, et al
    The COVID-NMA Project: Building an Evidence Ecosystem for the COVID-19 Pandemic.
    Ann Intern Med. 2020 Sep 15. doi: 10.7326/M20-5261.
    PubMed        

  13. MUNN Z, Twaddle S, Service D, Harrow E, et al
    Developing Guidelines Before, During, and After the COVID-19 Pandemic.
    Ann Intern Med. 2020 Sep 15. doi: 10.7326/M20-4907.
    PubMed        

  14. LONG B
    Low-dose chest CT had 95% sensitivity and 91% specificity for diagnosing COVID-19 in patients with clinical symptoms.
    Ann Intern Med. 2020;173:JC68.
    PubMed         Abstract available

  15. GEIJTEMAN ECT, Bosch FH, Smulders YM
    Universal Do-Not-Resuscitate Orders, Social Worth, and Life-Years.
    Ann Intern Med. 2020;173:1028-1029.
    PubMed        


    Antimicrob Agents Chemother

  16. ALEISSA MM, Silverman EA, Paredes Acosta LM, Nutt CT, et al
    New Perspectives on Antimicrobial Agents: Remdesivir Treatment for COVID-19.
    Antimicrob Agents Chemother. 2020;65.
    PubMed         Abstract available


    BMC Pediatr

  17. KANTAR A, Mazza A, Bonanomi E, Odoni M, et al
    COVID-19 and children with Down syndrome: is there any real reason to worry? Two case reports with severe course.
    BMC Pediatr. 2020;20:561.
    PubMed         Abstract available


    BMJ

  18. MOORE A, MacKenzie MK
    Policy making during crises: how diversity and disagreement can help manage the politics of expert advice.
    BMJ. 2020;371:m4039.
    PubMed        

  19. KAL EC, Young WR, Ellmers TJ
    Face masks, vision, and risk of falls.
    BMJ. 2020;371:m4133.
    PubMed        

  20. MCKEE M, van Schalkwyk MCI, Maani N, Galea S, et al
    A new year's resolution for health workers.
    BMJ. 2020;371:m4602.
    PubMed        

  21. MCLELLAN A, Godlee F
    Covid 19: Christmas relaxation will overwhelm services.
    BMJ. 2020;371:m4847.
    PubMed        

  22. SALAS RN
    Climate action: the best gift for global health.
    BMJ. 2020;371:m4723.
    PubMed        

  23. SO AD, Woo J
    Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis.
    BMJ. 2020;371:m4750.
    PubMed         Abstract available

  24. SEWELL HF, Agius RM, Kendrick D, Stewart M, et al
    Covid-19 vaccines: delivering protective immunity.
    BMJ. 2020;371:m4838.
    PubMed        


  25. Update to living WHO guideline on drugs for covid-19.
    BMJ. 2020;371:m4779.
    PubMed        


  26. Update to living systematic review on drug treatments for covid-19.
    BMJ. 2020;371:m4852.
    PubMed        

  27. WANG W, Wu Q, Yang J, Dong K, et al
    Global, regional, and national estimates of target population sizes for covid-19 vaccination: descriptive study.
    BMJ. 2020;371:m4704.
    PubMed         Abstract available

  28. SCHWARTZ JL
    Equitable global access to coronavirus disease 2019 vaccines.
    BMJ. 2020;371:m4735.
    PubMed        


    Eur J Epidemiol

  29. LEVIN AT, Hanage WP, Owusu-Boaitey N, Cochran KB, et al
    Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications.
    Eur J Epidemiol. 2020;35:1123-1138.
    PubMed         Abstract available


    J Clin Microbiol

  30. THEEL ES, Couturier MR, Filkins L, Palavecino E, et al
    Application, Verification, and Implementation of SARS-CoV-2 Serologic Assays with Emergency Use Authorization.
    J Clin Microbiol. 2020;59.
    PubMed         Abstract available

  31. TURBETT SE, Anahtar M, Dighe AS, Garcia Beltran W, et al
    Evaluation of Three Commercial SARS-CoV-2 Serologic Assays and Their Performance in Two-Test Algorithms.
    J Clin Microbiol. 2020;59.
    PubMed         Abstract available

  32. SCHUETZ AN, Hemarajata P, Mehta N, Campbell S, et al
    When Should Asymptomatic Persons Be Tested for COVID-19?
    J Clin Microbiol. 2020;59.
    PubMed         Abstract available

  33. YOUNG S, Taylor SN, Cammarata CL, Varnado KG, et al
    Clinical Evaluation of BD Veritor SARS-CoV-2 Point-of-Care Test Performance Compared to PCR-Based Testing and versus the Sofia 2 SARS Antigen Point-of-Care Test.
    J Clin Microbiol. 2020;59.
    PubMed         Abstract available

  34. ADDETIA A, Lin MJ, Peddu V, Roychoudhury P, et al
    Sensitive Recovery of Complete SARS-CoV-2 Genomes from Clinical Samples by Use of Swift Biosciences' SARS-CoV-2 Multiplex Amplicon Sequencing Panel.
    J Clin Microbiol. 2020;59.
    PubMed        

  35. ASSENNATO SM, Ritchie AV, Nadala C, Goel N, et al
    Performance Evaluation of the SAMBA II SARS-CoV-2 Test for Point-of-Care Detection of SARS-CoV-2.
    J Clin Microbiol. 2020;59.
    PubMed         Abstract available

  36. PISANIC N, Randad PR, Kruczynski K, Manabe YC, et al
    COVID-19 Serology at Population Scale: SARS-CoV-2-Specific Antibody Responses in Saliva.
    J Clin Microbiol. 2020;59.
    PubMed         Abstract available

  37. BABIKER A, Bradley HL, Stittleburg VD, Ingersoll JM, et al
    Metagenomic Sequencing To Detect Respiratory Viruses in Persons under Investigation for COVID-19.
    J Clin Microbiol. 2020;59.
    PubMed         Abstract available

  38. VANAERSCHOT M, Mann SA, Webber JT, Kamm J, et al
    Identification of a Polymorphism in the N Gene of SARS-CoV-2 That Adversely Impacts Detection by Reverse Transcription-PCR.
    J Clin Microbiol. 2020;59.
    PubMed        

  39. SHAKIR SM, Barker AP, Hillyard DR, Gilmore N, et al
    Combined Self-Collected Anterior Nasal and Oropharyngeal Specimens versus Provider-Collected Nasopharyngeal Swabs for the Detection of SARS-CoV-2.
    J Clin Microbiol. 2020;59.
    PubMed        

  40. BORMAN AM, Palmer MD, Fraser M, Patterson Z, et al
    COVID-19 associated invasive aspergillosis: data from the UK National Mycology Reference Laboratory.
    J Clin Microbiol. 2020 Oct 21. pii: JCM.02136-20. doi: 10.1128/JCM.02136.
    PubMed         Abstract available

  41. KOCIOLEK LK, Muller WJ, Yee R, Dien Bard J, et al
    Comparison of Upper Respiratory Viral Load Distributions in Asymptomatic and Symptomatic Children Diagnosed with SARS-CoV-2 Infection in Pediatric Hospital Testing Programs.
    J Clin Microbiol. 2020;59.
    PubMed         Abstract available

  42. HARLEY K, Gunsolus IL
    Comparison of the Clinical Performances of the Abbott Alinity IgG, Abbott Architect IgM, and Roche Elecsys Total SARS-CoV-2 Antibody Assays.
    J Clin Microbiol. 2020;59.
    PubMed         Abstract available


    J Epidemiol Community Health

  43. ZHANG Y, Muscatello D, Tian Y, Chen Y, et al
    Role of presymptomatic transmission of COVID-19: evidence from Beijing, China.
    J Epidemiol Community Health. 2021;75:84-87.
    PubMed         Abstract available


    J Infect

  44. BI J, Lin Y, Zhong R, Jiang G, et al
    Prevalence and Clinical Characterization of Cancer Patients with Asymptomatic SARS-CoV-2 Infection History.
    J Infect. 2020 Jul 22. pii: S0163-4453(20)30493.
    PubMed        

  45. PALLETT SJC, Jones R, Pallett MA, Rayment M, et al
    Characterising differential antibody response is integral to future SARS-CoV-2 serostudies.
    J Infect. 2020 Jul 30. pii: S0163-4453(20)30511.
    PubMed        

  46. HAMILTON F, Muir P, Attwood M, Vipond ANB, et al
    Kinetics and performance of the Abbott Architect SARS-CoV-2 IgG antibody assay.
    J Infect. 2020 Jul 30. pii: S0163-4453(20)30510.
    PubMed        

  47. WANG Y, Chow A
    Dancing with COVID-19 after the Hammer is Lifted: Enhancing Healthcare Worker Surveillance.
    J Infect. 2020 Aug 1. pii: S0163-4453(20)30533.
    PubMed        

  48. HAN J, Gong H, Fu L, Chen P, et al
    Clinical and CT imaging features of SARS-CoV-2 patients presented with diarrhea.
    J Infect. 2020 Aug 5. pii: S0163-4453(20)30536.
    PubMed        

  49. SADDIQUE A, Rana MS, Alam MM, Ikram A, et al
    "Emergence of co-infection of COVID-19 and dengue: A serious public health threat ".
    J Infect. 2020 Aug 12. pii: S0163-4453(20)30545.
    PubMed        

  50. LIM RH, Chow A, Ho HJ
    Decline in pneumococcal disease incidence in the time of COVID-19 in Singapore.
    J Infect. 2020 Aug 15. pii: S0163-4453(20)30554.
    PubMed        

  51. BONGIOVANNI M, Vignati M, Giuliani G, Manes G, et al
    The dilemma of COVID-19 recurrence after clinical recovery.
    J Infect. 2020 Aug 15. pii: S0163-4453(20)30553.
    PubMed        

  52. LANDI F, Gremese E, Rota E, Carfi' A, et al
    Positive RT-PCR nasopharyngeal swab in patients recovered from COVID-19 disease: When does quarantine really end?
    J Infect. 2020 Aug 24. pii: S0163-4453(20)30565.
    PubMed        

  53. LEI H, Xu X, Xiao S, Wu X, et al
    Household transmission of COVID-19-a systematic review and meta-analysis.
    J Infect. 2020 Aug 25. pii: S0163-4453(20)30571.
    PubMed        

  54. PAGANI G, Conti F, Giacomelli A, Bernacchia D, et al
    Seroprevalence of SARS-CoV-2 significantly varies with age: preliminary results from a mass population screening.
    J Infect. 2020 Sep 19. pii: S0163-4453(20)30629.
    PubMed        

  55. GUO J, Yu H, Yang J, Li Y, et al
    Weighted gene co-expression network analysis revealed host transcriptional response to H1N1 influenza A virus infection.
    J Infect. 2020 Dec 29. pii: S0163-4453(20)30779.
    PubMed        


    J Infect Dis

  56. TENFORDE MW, Talbot HK, Trabue CH, Gaglani M, et al
    Influenza vaccine effectiveness against hospitalization in the United States, 2019-2020.
    J Infect Dis. 2020 Dec 30. pii: 6055595. doi: 10.1093.
    PubMed         Abstract available


    J Virol

  57. LI Z, Qu X, Liu X, Huan C, et al
    GBP5 Is an Interferon-Induced Inhibitor of Respiratory Syncytial Virus.
    J Virol. 2020;94.
    PubMed         Abstract available

  58. VERHAGEN JH, Eriksson P, Leijten L, Blixt O, et al
    Host range of influenza A virus H1 to H16 in Eurasian ducks based on tissue and receptor binding studies.
    J Virol. 2020 Dec 23. pii: JVI.01873-20. doi: 10.1128/JVI.01873.
    PubMed         Abstract available

  59. WANG Q, Pan W, Wang S, Pan C, et al
    Protein tyrosine phosphatase SHP2 suppresses host innate immunity against influenza A virus through regulating EGFR-mediated signaling.
    J Virol. 2020 Dec 23. pii: JVI.02001-20. doi: 10.1128/JVI.02001.
    PubMed         Abstract available


    Lancet

  60. BRIGGS ADM, Fraser C
    Is NHS Test and Trace exacerbating COVID-19 inequalities?
    Lancet. 2020 Dec 4. pii: S0140-6736(20)32593.
    PubMed        

  61. RAMASAMY MN, Minassian AM, Ewer KJ, Flaxman AL, et al
    Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
    Lancet. 2020 Nov 18. pii: S0140-6736(20)32466.
    PubMed         Abstract available

  62. CHANDAN JS
    Improving global surveillance of gender-based violence.
    Lancet. 2020;396:1562.
    PubMed        

  63. AL KNAWY B, Adil M, Crooks G, Rhee K, et al
    The Riyadh Declaration: the role of digital health in fighting pandemics.
    Lancet. 2020;396:1537-1539.
    PubMed        

  64. THE LANCET
    Science during COVID-19: where do we go from here?
    Lancet. 2021;396:1941.
    PubMed        


    N Engl J Med

  65. WALSH EE, Frenck RW Jr, Falsey AR, Kitchin N, et al
    Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.
    N Engl J Med. 2020 Oct 14. doi: 10.1056/NEJMoa2027906.
    PubMed         Abstract available

  66. ANDERSON EJ, Rouphael NG, Widge AT, Jackson LA, et al
    Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.
    N Engl J Med. 2020 Sep 29. doi: 10.1056/NEJMoa2028436.
    PubMed         Abstract available

  67. LEICK MB
    Telephone.
    N Engl J Med. 2020;383:2304-2305.
    PubMed        

  68. BERLIN DA, Gulick RM, Martinez FJ
    Severe Covid-19.
    N Engl J Med. 2020 May 15. doi: 10.1056/NEJMcp2009575.
    PubMed        

  69. KASPER MR, Geibe JR, Sears CL, Riegodedios AJ, et al
    An Outbreak of Covid-19 on an Aircraft Carrier.
    N Engl J Med. 2020 Nov 11. doi: 10.1056/NEJMoa2019375.
    PubMed         Abstract available

  70. HUNTER DJ
    Trying to "Protect the NHS" in the United Kingdom.
    N Engl J Med. 2020;383:e136.
    PubMed        

  71. LETIZIA AG, Ramos I, Obla A, Goforth C, et al
    SARS-CoV-2 Transmission among Marine Recruits during Quarantine.
    N Engl J Med. 2020 Nov 11. doi: 10.1056/NEJMoa2029717.
    PubMed         Abstract available

  72. KENNEDY BS, Richeson RP, Houde AJ
    Risk Factors for SARS-CoV-2 in a Statewide Correctional System.
    N Engl J Med. 2020 Nov 24. doi: 10.1056/NEJMc2029354.
    PubMed        

  73. KARIM M, Ghoussaini M, Dunham I
    Mining a GWAS of Severe Covid-19.
    N Engl J Med. 2020;383.
    PubMed        

  74. KATZ DH, Wilson JG, Gerszten RE
    Mining a GWAS of Severe Covid-19.
    N Engl J Med. 2020;383.
    PubMed        

  75. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Covid-19 Vaccine Fundamentals.
    N Engl J Med. 2020;383:e146.
    PubMed        


    PLoS Biol

  76. KIM JI, Park S, Bae JY, Lee S, et al
    Glycosylation generates an efficacious and immunogenic vaccine against H7N9 influenza virus.
    PLoS Biol. 2020;18:e3001024.
    PubMed         Abstract available


    PLoS Genet

  77. TURAKHIA Y, De Maio N, Thornlow B, Gozashti L, et al
    Stability of SARS-CoV-2 phylogenies.
    PLoS Genet. 2020;16:e1009175.
    PubMed         Abstract available


    PLoS One

  78. BELLO-CHAVOLLA OY, Antonio-Villa NE, Ortiz-Brizuela E, Vargas-Vazquez A, et al
    Validation and repurposing of the MSL-COVID-19 score for prediction of severe COVID-19 using simple clinical predictors in a triage setting: The Nutri-CoV score.
    PLoS One. 2020;15:e0244051.
    PubMed         Abstract available

  79. TAN SY, Tey HL, Lim ETH, Toh ST, et al
    The accuracy of healthcare worker versus self collected (2-in-1) Oropharyngeal and Bilateral Mid-Turbinate (OPMT) swabs and saliva samples for SARS-CoV-2.
    PLoS One. 2020;15:e0244417.
    PubMed         Abstract available

  80. KUMAR A, Kasloff SB, Leung A, Cutts T, et al
    Decontamination of N95 masks for re-use employing 7 widely available sterilization methods.
    PLoS One. 2020;15:e0243965.
    PubMed         Abstract available

  81. KALYANARAMAN MARCELLO R, Dolle J, Grami S, Adule R, et al
    Characteristics and outcomes of COVID-19 patients in New York City's public hospital system.
    PLoS One. 2020;15:e0243027.
    PubMed         Abstract available

  82. TORDJMAN M, Mekki A, Mali RD, Saab I, et al
    Pre-test probability for SARS-Cov-2-related infection score: The PARIS score.
    PLoS One. 2020;15:e0243342.
    PubMed         Abstract available

  83. FRIEDRICH MS, Studt JD, Braun J, Spahn DR, et al
    Coronavirus-induced coagulopathy during the course of disease.
    PLoS One. 2020;15:e0243409.
    PubMed         Abstract available

  84. WIECZOREK M, Silka J, Polap D, Wozniak M, et al
    Real-time neural network based predictor for cov19 virus spread.
    PLoS One. 2020;15:e0243189.
    PubMed         Abstract available

  85. DHONGDE S
    Multidimensional economic deprivation during the coronavirus pandemic: Early evidence from the United States.
    PLoS One. 2020;15:e0244130.
    PubMed         Abstract available

  86. CARRILLO HERNANDEZ-RUBIO J, Sanchez-Carpintero Abad M, Yordi Leon A, Doblare Higuera G, et al
    Outcomes of an intermediate respiratory care unit in the COVID-19 pandemic.
    PLoS One. 2020;15:e0243968.
    PubMed         Abstract available

  87. MOSTAGHIM A, Sinha P, Bielick C, Knudsen S, et al
    Clinical outcomes and inflammatory marker levels in patients with Covid-19 and obesity at an inner-city safety net hospital.
    PLoS One. 2020;15:e0243888.
    PubMed         Abstract available

  88. BORIE R, Savale L, Dossier A, Ghosn J, et al
    Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: A cohort study.
    PLoS One. 2020;15:e0243961.
    PubMed         Abstract available

  89. KAUSHAL S, Rajput AS, Bhattacharya S, Vidyasagar M, et al
    Estimating the herd immunity threshold by accounting for the hidden asymptomatics using a COVID-19 specific model.
    PLoS One. 2020;15:e0242132.
    PubMed         Abstract available

  90. MACEDO MCF, Pinheiro IM, Carvalho CJL, Fraga HCJR, et al
    Correlation between hospitalized patients' demographics, symptoms, comorbidities, and COVID-19 pandemic in Bahia, Brazil.
    PLoS One. 2020;15:e0243966.
    PubMed         Abstract available

  91. ALTONEN BL, Arreglado TM, Leroux O, Murray-Ramcharan M, et al
    Characteristics, comorbidities and survival analysis of young adults hospitalized with COVID-19 in New York City.
    PLoS One. 2020;15:e0243343.
    PubMed         Abstract available

  92. LAPLANA M, Yuguero O, Fibla J
    Lack of protective effect of chloroquine derivatives on COVID-19 disease in a Spanish sample of chronically treated patients.
    PLoS One. 2020;15:e0243598.
    PubMed         Abstract available

  93. KILANI HA, Bataineh MF, Al-Nawayseh A, Atiyat K, et al
    Healthy lifestyle behaviors are major predictors of mental wellbeing during COVID-19 pandemic confinement: A study on adult Arabs in higher educational institutions.
    PLoS One. 2020;15:e0243524.
    PubMed         Abstract available

  94. GRIMA N, Corcoran W, Hill-James C, Langton B, et al
    The importance of urban natural areas and urban ecosystem services during the COVID-19 pandemic.
    PLoS One. 2020;15:e0243344.
    PubMed         Abstract available

  95. SMITH SL, Golden AS, Ramenzoni V, Zemeckis DR, et al
    Adaptation and resilience of commercial fishers in the Northeast United States during the early stages of the COVID-19 pandemic.
    PLoS One. 2020;15:e0243886.
    PubMed         Abstract available

  96. ZHU S, Gao Q, Yang L, Yang Y, et al
    Prevalence and risk factors of disability and anxiety in a retrospective cohort of 432 survivors of Coronavirus Disease-2019 (Covid-19) from China.
    PLoS One. 2020;15:e0243883.
    PubMed         Abstract available

  97. CHIMOYI L, Velen K, Churchyard GJ, Wallis R, et al
    An ecological study to evaluate the association of Bacillus Calmette-Guerin (BCG) vaccination on cases of SARS-CoV2 infection and mortality from COVID-19.
    PLoS One. 2020;15:e0243707.
    PubMed         Abstract available

  98. DO PC, Nguyen TH, Vo UHM, Le L, et al
    iBRAB: In silico based-designed broad-spectrum Fab against H1N1 influenza A virus.
    PLoS One. 2020;15:e0239112.
    PubMed         Abstract available

  99. SHANE HL, Othumpangat S, Marshall NB, Blachere F, et al
    Topical exposure to triclosan inhibits Th1 immune responses and reduces T cells responding to influenza infection in mice.
    PLoS One. 2020;15:e0244436.
    PubMed         Abstract available

  100. LIU Q, Brookbank L, Ho A, Coffey J, et al
    Surface texture limits transfer of S. aureus, T4 bacteriophage, influenza B virus and human coronavirus.
    PLoS One. 2020;15:e0244518.
    PubMed         Abstract available

  101. PATTABIRAMAN C, Habib F, P K H, Rasheed R, et al
    Genomic epidemiology reveals multiple introductions and spread of SARS-CoV-2 in the Indian state of Karnataka.
    PLoS One. 2020;15:e0243412.
    PubMed         Abstract available

  102. MIN J
    Does social trust slow down or speed up the transmission of COVID-19?
    PLoS One. 2020;15:e0244273.
    PubMed         Abstract available

  103. PINCHOFF J, Santhya KG, White C, Rampal S, et al
    Gender specific differences in COVID-19 knowledge, behavior and health effects among adolescents and young adults in Uttar Pradesh and Bihar, India.
    PLoS One. 2020;15:e0244053.
    PubMed         Abstract available

  104. JOKIC-BEGIC N, Lauri Korajlija A, Mikac U
    Cyberchondria in the age of COVID-19.
    PLoS One. 2020;15:e0243704.
    PubMed         Abstract available

  105. HIRANO H, Koga K, Takemoto K
    Vulnerability of deep neural networks for detecting COVID-19 cases from chest X-ray images to universal adversarial attacks.
    PLoS One. 2020;15:e0243963.
    PubMed         Abstract available

  106. WANG J, Guo S, Zhang Y, Gao K, et al
    Clinical features and risk factors for severe inpatients with COVID-19: A retrospective study in China.
    PLoS One. 2020;15:e0244125.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  107. ZENG HL, Dichio V, Rodriguez Horta E, Thorell K, et al
    Global analysis of more than 50,000 SARS-CoV-2 genomes reveals epistasis between eight viral genes.
    Proc Natl Acad Sci U S A. 2020;117:31519-31526.
    PubMed         Abstract available

  108. MUELLER JT, McConnell K, Burow PB, Pofahl K, et al
    Impacts of the COVID-19 pandemic on rural America.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  109. LIU K, Tan S, Niu S, Wang J, et al
    Cross-species recognition of SARS-CoV-2 to bat ACE2.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


    Vaccine

  110. THANGARAJAH D, Malo JA, Field E, Andrews R, et al
    Effectiveness of quadrivalent influenza vaccination in the first year of a funded childhood program in Queensland, Australia, 2018.
    Vaccine. 2020 Dec 23. pii: S0264-410X(20)31579.
    PubMed         Abstract available

  111. MCFADDEN K, Seale H
    A review of hospital-based interventions to improve inpatient influenza vaccination uptake for high-risk adults.
    Vaccine. 2020 Dec 21. pii: S0264-410X(20)31610.
    PubMed         Abstract available

  112. MORO PL, Marquez P
    Reports of cell-based influenza vaccine administered during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 2013-2020.
    Vaccine. 2020 Dec 24. pii: S0264-410X(20)31613.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: